FY13: "phenotypic screening of smoking cessation drugs," N43DA-13-7786: purpose: to fund base award of sbir phase I contract; POP: 8/30/2013 - 8/29/2014.
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201300037C
- Awardee
-
Afasci, Inc. UEI UGMEBNM4WSL6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $338,884
Award facts
- Contract value 100% obligated
- $338,884.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Hillsborough, CA 94010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $338,884 |
Quick answers
Who was awarded contract HHSN271201300037C?
HHSN271201300037C was awarded to Afasci, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 30, 2013.
How much is contract HHSN271201300037C worth?
The government has obligated $338,884 on HHSN271201300037C.
Was contract HHSN271201300037C competed?
The extent of competition for HHSN271201300037C was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award